Arthritis drug shows ‘significant’ promise in severe Covid-19 cases, says study | The Malaysian Insight

United States News News

Arthritis drug shows ‘significant’ promise in severe Covid-19 cases, says study | The Malaysian Insight
United States Latest News,United States Headlines
  • 📰 msianinsight
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

Arthritis drug shows ‘significant’ promise in severe Covid-19 cases, says study

Several existing drugs, including anti-viral medicines, are currently being trialled worldwide to treat Covid-19. – EPA pic, April 28, 2020.

THE arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill Covid-19 patients, according to a French clinical study. The treatment, which suppresses the body’s natural immune response, was found to reduce “significantly” the number of deaths or life support interventions compared with a control group of patients.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one week free access!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

msianinsight /  🏆 8. in MY

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Hopes for Covid-19 drug dashed in virus trial | The Malaysian InsightHopes for Covid-19 drug dashed in virus trial | The Malaysian InsightArthritis drug does not attack Covid-19 but inhibits cytokine storm.
Read more »

Closely watched arthritis drug disappoints in Covid-19 trial | Malay MailClosely watched arthritis drug disappoints in Covid-19 trial | Malay MailWASHINGTON, April 28 — An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said yesterday. Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus but instead...
Read more »

Closely watched arthritis drug disappoints in Covid-19 trialClosely watched arthritis drug disappoints in Covid-19 trialWASHINGTON (AFP): An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said on Monday (April 27).
Read more »

After Remdesivir, second drug disappoints in Covid-19 trial | New Straits TimesAfter Remdesivir, second drug disappoints in Covid-19 trial | New Straits TimesNSTworld: An arthritis drug that was being closely watched for its potential use against Covid19 has delivered disappointing results in clinical trials, its makers said. coronavirus Kevzara
Read more »

Singapore confirms 799 new Covid-19 casesSingapore confirms 799 new Covid-19 casesTHE island state confirmed 799 new Covid-19 cases yesterday, taking the total count to 14,423.
Read more »

Covid-19: 40 new cases, death toll now at 99Covid-19: 40 new cases, death toll now at 99PUTRAJAYA: Malaysia reported 40 more Covid-19 cases on Monday (April 27), bringing the total number of Covid-19 infections in the country to 5,820.
Read more »



Render Time: 2025-03-09 17:12:41